These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7462334)

  • 1. Inhibition of calcium and glucose uptake by murine leukemia L5178Y cells treated with antiserum.
    Woodcock-Mitchell J; Yang TJ
    J Cell Physiol; 1980 Dec; 105(3):423-9. PubMed ID: 7462334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of SW620 cells with Tomudex and oxaliplatin induces changes in 2-deoxy-D-glucose incorporation associated with modifications in glucose transport.
    Smith TA; Maisey NR; Titley JC; Jackson LE; Leach MO; Ronen SM
    J Nucl Med; 2000 Oct; 41(10):1753-9. PubMed ID: 11038008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of growth of the L5178Y murine lymphoma by means of immunization with radiated L5178Y cells.
    Ramos-Damián M; Gómez-Estrada H; Acosta-Ruiz R; Díaz-Esquivel P; Vázquez-Escobosa C
    Arch Invest Med (Mex); 1982; 13(1):29-31. PubMed ID: 7065806
    [No Abstract]   [Full Text] [Related]  

  • 4. Location of tumoral antigens in L5178Y murine lymphoma cells.
    Ramos-Damián ME; Gómez-Estrada H; Hernández-Delgado J; Tapia-Arizmendi L; Feria-Velasco A
    Arch Invest Med (Mex); 1980; 11(3):425-34. PubMed ID: 7469659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and decomposition of chlorozotocin in L5178Y lymphoblasts in vitro.
    Lam HY; Talgoy MM; Goldenberg GJ
    Cancer Res; 1980 Nov; 40(11):3950-5. PubMed ID: 6451281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of growth of ASL-1w murine leukemia cells by anti-thymus leukemia antigen (TL) serum in the absence of complement.
    Wolcott M; Pickering JW; Williams JL
    J Immunol; 1979 Nov; 123(5):1985-8. PubMed ID: 489968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human erythrocyte sugar transport is incompatible with available carrier models.
    Cloherty EK; Heard KS; Carruthers A
    Biochemistry; 1996 Aug; 35(32):10411-21. PubMed ID: 8756697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologic changes in the murine leukemia L5178Y cells treated with antibodies in the absence of complement activity.
    Yang TJ; Haddad-Khairallah L; Wachtel A
    Exp Mol Pathol; 1981 Aug; 35(1):137-52. PubMed ID: 6166498
    [No Abstract]   [Full Text] [Related]  

  • 9. Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes.
    Stouthard JM; Oude Elferink RP; Sauerwein HP
    Biochem Biophys Res Commun; 1996 Mar; 220(2):241-5. PubMed ID: 8645290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genistein inhibits insulin-stimulated glucose transport and decreases immunocytochemical labeling of GLUT4 carboxyl-terminus without affecting translocation of GLUT4 in isolated rat adipocytes: additional evidence of GLUT4 activation by insulin.
    Smith RM; Tiesinga JJ; Shah N; Smith JA; Jarett L
    Arch Biochem Biophys; 1993 Jan; 300(1):238-46. PubMed ID: 8424658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of membrane transport of 5-fluoro[6-3H]deoxyuridine into L5178Y mouse leukemia cells.
    Wigler PW; Schluter DN
    Cancer Res; 1976 Sep; 36(9 pt.1):3207-11. PubMed ID: 135641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic effects of glucose on insulin signaling in A-10 vascular smooth muscle cells.
    Cooper DR; Khalakdina A; Watson JE
    Arch Biochem Biophys; 1993 May; 302(2):490-8. PubMed ID: 8489251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 25-Hydroxycholesterol-induced elevation in 45Ca uptake: correlation with depressed DNA synthesis.
    Boissonneault GA; Heiniger HJ
    J Cell Physiol; 1984 Aug; 120(2):151-6. PubMed ID: 6430918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uniaxial cyclic stretch-stimulated glucose transport is mediated by a ca-dependent mechanism in cultured skeletal muscle cells.
    Iwata M; Hayakawa K; Murakami T; Naruse K; Kawakami K; Inoue-Miyazu M; Yuge L; Suzuki S
    Pathobiology; 2007; 74(3):159-68. PubMed ID: 17643061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour cell-antibody interactions. I. In vivo experiments.
    Froese G; Berczi I; Israels LG
    Immunology; 1982 Feb; 45(2):303-12. PubMed ID: 7061100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth-promoting activity of desmopressin in murine leukemia cells treated in vitro.
    Beenken SW; Batra JK; Gerrard JM; Goldenberg GJ
    Cancer Res; 1988 Dec; 48(24 Pt 1):7055-9. PubMed ID: 3191481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular weight inhibitory factor released in vitro by murine L5178Y leukemic cells.
    Chmurzyńska W; Grzelakowska-Sztabert B
    Neoplasma; 1987; 34(5):513-21. PubMed ID: 2447509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Deoxy-D-[1-3H]glucose uptake by MCF7 and T47D breast tumour cells under conditions of active proliferation and serum deprivation.
    Smith TA; Title JC; Eccles SA; McCready VR
    Anticancer Res; 1998; 18(3A):1865-9. PubMed ID: 9673417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of misonidazole on L5178Y-R and L5178Y-S cells. I. Comparison with antimycin A and potassium cyanide under aerobic conditions.
    Budzicka E; Niepokojczycka E; Szumiel I
    Neoplasma; 1981; 28(4):423-33. PubMed ID: 7290266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells.
    Kominsky DJ; Klawitter J; Brown JL; Boros LG; Melo JV; Eckhardt SG; Serkova NJ
    Clin Cancer Res; 2009 May; 15(10):3442-50. PubMed ID: 19401345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.